2007
DOI: 10.1002/art.23097
|View full text |Cite
|
Sign up to set email alerts
|

Delay in imaging versus clinical response: A rationale for prolonged treatment with anti–tumor necrosis factor medication in early rheumatoid arthritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
38
0
1

Year Published

2008
2008
2013
2013

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 65 publications
(43 citation statements)
references
References 8 publications
4
38
0
1
Order By: Relevance
“…Although this is to be expected, as lower cut-off points will include fewer swollen or tender joints and therefore lower assessments of disease activity, it also indicates that SDAI is able to capture some of the influence of residual disease activity, which can be present in subclinical synovitis in patients in clinical remission [11]. Further studies are required to assess whether these findings are also associated with clinically significant outcomes.…”
Section: Discussionmentioning
confidence: 98%
See 3 more Smart Citations
“…Although this is to be expected, as lower cut-off points will include fewer swollen or tender joints and therefore lower assessments of disease activity, it also indicates that SDAI is able to capture some of the influence of residual disease activity, which can be present in subclinical synovitis in patients in clinical remission [11]. Further studies are required to assess whether these findings are also associated with clinically significant outcomes.…”
Section: Discussionmentioning
confidence: 98%
“…Both scores are useful in assessing moderate or high disease activity or therapeutic responses, and correlate with changes in sensible imaging techniques like US [12,27]. A number of studies have reported the superiority of US over clinical evaluation for detecting joint inflammation [11,[28][29][30][31][32]. Our results confirm previous reports showing that US-detected active synovitis, which is often subclinical, is present in patients in clinical remission, although these studies were carried out using small numbers of patients or joints [11,13,14].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…This means that imaging studies enable assessment of patients independent of clinical examinations. In this regard, many studies reported that synovitis detected on MRI or flow signal on PD-US progresses to bone destruction [28][29][30]. Taking these results into account, absence of synovitis or bone edema on MRI, or lack of flow signal on PD-US, could represent imaging criteria for remission and information that could help in clinical decision-making regarding discontinuation of biological treatment.…”
Section: Discussionmentioning
confidence: 95%